Xinhua
04 Feb 2023, 02:00 GMT+10
More than 1,321 recalls were issued last year for human drug products that were defective or violated laws enforced by the U.S. Food and Drug Administration, "the highest figure in the past three years," USA TODAY said.
NEW YORK, Feb. 3 (Xinhua) -- More drugs were recalled last year in the United States and the annual price rise came with less impact this year, in the wake of three years of the COVID-19 pandemic with patients having to face a much paler health landscape.
LARGEST RECALL
More than 1,321 recalls were issued last year for human drug products that were defective or violated laws enforced by the U.S. Food and Drug Administration (FDA), "the highest figure in the past three years," said USA TODAY upon its analysis of FDA data.
Almost 90 percent of 2022 drug recalls were for problems the FDA said could cause a temporary health issue and posed only a slight threat of a serious nature, said the report.
An additional 10 percent of recalls were for products the FDA said are unlikely to cause any adverse health reaction but ran afoul of FDA labeling or manufacturing laws, it noted.
A total of 83 recalls last year were in the FDA's highest risk category, meaning they stemmed from drug problems the agency said "predictably could cause serious health problems or death," according to the report.
Most recalls happened because either a company discovered a problem, or the FDA raised concerns.
Only on very rare occasions does the FDA take legal action, typically against manufacturers that persist in marketing a defective product, said the newspaper.
"Only 29 of the 14,732 recalls that were issued since 2012, when the data was first published, were mandated by the federal agency," it added.
MILD PRICE RISE
With pharmaceutical companies hiking prices on nearly 1,000 drugs in January, some consumers might experience sticker shock next time they pick up prescriptions.
"Pharmaceutical companies raised list prices of 983 arthritis, cancer and other prescription drugs by an average of 5.6 percent at the start of this year -- restrained increases as the industry faces a new federal law aimed at lowering medicine costs," reported The Wall Street Journal (WSJ) on Friday.
"The price increases come as a new federal law requires companies to pay Medicare a rebate if they increase prices above the rate of inflation," said USA TODAY at the end of the first month.
Other Inflation Reduction Act provisions, such as capping Medicare recipients' out-of-pocket expenses at 2,000 U.S. dollars and allowing Medicare to negotiate the costliest drugs, haven't kicked in yet it noted.
Drugmakers usually begin a new year by raising the list prices of their products. After several years taking increases of 10 percent or more on certain medicines, the companies have moderated their moves more recently.
Major drug companies such as AbbVie, Pfizer and Bristol-Myers Squibb have raised prices so far, according to data provided by 46brooklyn Research, a nonprofit that researches drug pricing.
Drug affordability remains a top worry for consumers. About 3 in 10 people don't take a drug as prescribed over concerns about cost -- some don't fill prescriptions, others skip doses or sought cheaper over-the-counter medication, according to a Kaiser Family Foundation poll last year.
Get a daily dose of Maryland Leader news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Maryland Leader.
More InformationWASHINGTON, D.C.: The Trump administration has made public a visa decision that would usually be kept private. It did this to send...
MADRID, Spain: Liverpool footballer Diogo Jota and his younger brother, André Silva, have died in a car accident in Spain. Spanish...
LONDON, U.K.: An unrelenting heatwave sweeping across Europe has pushed early summer temperatures to historic highs, triggering deadly...
President Donald Trump's plans to build a space-based Golden Dome missile defense shield have drawn immediate criticism from China,...
NEW YORK CITY, New York: Paramount has agreed to pay US$16 million to settle a lawsuit brought by U.S. President Donald Trump over...
LONDON, U.K.: British Prime Minister Keir Starmer won a vote in Parliament this week to move ahead with changes to the country's welfare...
PALO ALTO/TEL AVIV: The battle for top AI talent has claimed another high-profile casualty—this time at Safe Superintelligence (SSI),...
FRANKLIN, Tennessee: Hundreds of thousands of Nissan and Infiniti vehicles are being recalled across the United States due to a potential...
REDMOND, Washington: Microsoft is the latest tech giant to announce significant job cuts, as the financial strain of building next-generation...
LONDON UK - U.S. stock markets were closed on Friday for Independence Day. Global Forex Markets Wrap Up Friday with Greeback Comeback...
SANTA CLARA, California: Nvidia came within a whisker of making financial history on July 3, briefly surpassing Apple's all-time market...
SACRAMENTO, California: California's multibillion-dollar farms are facing a growing crisis—not from drought or pests, but from a sudden...